Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 45.71B | 44.74B | 49.34B | 53.95B | 39.11B | 33.15B |
Gross Profit | 17.09B | 23.88B | 23.30B | 20.20B | 17.06B | 16.14B |
EBITDA | 17.58B | 17.53B | 13.92B | 12.77B | 11.80B | 10.12B |
Net Income | 6.42B | 4.80B | 4.80B | 4.34B | 3.88B | 3.61B |
Balance Sheet | ||||||
Total Assets | 153.79B | 158.29B | 150.03B | 154.67B | 141.75B | 122.52B |
Cash, Cash Equivalents and Short-Term Investments | 7.02B | 4.57B | 3.81B | 4.99B | 4.54B | 3.79B |
Total Debt | 48.21B | 57.73B | 61.65B | 50.42B | 44.27B | 40.51B |
Total Liabilities | 89.99B | 97.24B | 89.74B | 96.55B | 85.63B | 75.30B |
Stockholders Equity | 46.66B | 47.13B | 43.11B | 41.12B | 40.48B | 35.41B |
Cash Flow | ||||||
Free Cash Flow | 6.45B | 2.05B | 4.25B | 3.66B | 1.19B | 2.50B |
Operating Cash Flow | 10.74B | 11.93B | 12.13B | 10.44B | 8.11B | 8.35B |
Investing Cash Flow | -144.00M | -8.40B | -9.69B | -10.15B | -9.49B | -6.64B |
Financing Cash Flow | -2.92B | -2.27B | -4.09B | 151.00M | 1.87B | -71.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $121.72B | 22.85 | 10.48% | 2.94% | -4.55% | -21.12% | |
80 Outperform | $6.30B | 4.32 | 26.38% | 72.95% | -4.14% | 13.02% | |
78 Outperform | $6.47B | 12.65 | 9.22% | 3.48% | -7.02% | 17.33% | |
73 Outperform | $49.15B | 16.58 | 9.76% | 3.42% | -0.39% | 0.75% | |
67 Neutral | $16.41B | 16.95 | 4.63% | 3.59% | 4.77% | 6.10% | |
64 Neutral | $21.90B | 2,867.59 | 0.47% | 5.12% | 12.40% | -108.27% | |
53 Neutral | $7.63B | 5.85 | 29.79% | 6.57% | -3.22% | 141.11% |